The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1963, 90: 324-328.
Copyright © 1963 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, E. D.
Right arrow Articles by Ferrebee, J. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Thomas, E. D.
Right arrow Articles by Ferrebee, J. W.

The Effect of Methotrexate on the Production of Antibodies against Attenuated Distemper Virus in the Dog1

E. Donnall Thomas, James A. Baker and Joseph W. Ferrebee

From the Mary Imogene Bassett Hospital (Affiliated with Columbia University) Cooperstown, N.Y. and Veterinary Virus Research Institute, Cornell University, Ithaca, New York

Abstract

Methotrexate is a potent inhibitor of antibody production in the dog at dose levels that are not in themselves productive of serious toxicity. In the absence of antibody production inoculation with the attenuated virus of distemper vaccine causes a fatal illness. The production of a fatal illness by this usually benign vaccine virus illustrates the heightened hazard of infection in subjects whose immunologic responsiveness is reduced by chemotherapy.

Footnotes

1 Supported by Research Grants A2215 and C2643 from the United States Public Health Service and by Contract AT(30-1)-2005 from the United States Atomic Energy Commission.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1963 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1963 by The American Association of Immunologists, Inc. All rights reserved.